SEC Info - Hinnen Dr A Francois, et al. - ‘SC 13G’ on 2/14/97 re: Institutional Equity Holdings Inc/NV

SEC Info℠

Home

Help

Please Sign In

Hinnen Dr A Francois, et al. – ‘SC 13G’ on 2/14/97 re: Institutional Equity Holdings Inc/NV

As of: Friday, 2/14/97 · Accession #: 950134-97-1076 · File #: 5-50045

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 2/14/97  Hinnen Dr A Francois              SC 13G                 1:12K  Inst’l Equity Holdings Inc/NV     RR Donnelley
          B.V. Wisteria
          Hinnen Dr A Francois
          Pantapharma B.V.

Statement of Beneficial Ownership — Schedule 13G
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13G      Statement of Beneficial Ownership                      8     26K

Document Table of Contents

Page	(sequential)	\|	(alphabetic)	Top
			Alternative Formats (Word, et al.) Address of Issuer's Principal Executive Offices Address of Principal Business Office or, if none, Residence Certification Citizenship CUSIP Number Identification and Classification of Members of the Group Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company Name of Issuer Name of Person Filing Not Applicable Notice of Dissolution of Group Ownership Ownership of Five Percent or Less of a Class Ownership of More than Five Percent on Behalf of Another Person Title of Class of Securities
1	1st Page - Filing Submission
5	Item 1(a). Name of Issuer
"	Item 1(b). Address of Issuer's Principal Executive Offices
"	Item 2(a). Name of Person Filing
"	Item 2(b). Address of Principal Business Office or, if none, Residence
"	Item 2(c). Citizenship
"	Item 2(d). Title of Class of Securities
"	Item 2(e). CUSIP Number
"	Item 3. Not Applicable
"	Item 4. Ownership
6	Item 5. Ownership of Five Percent or Less of a Class
"	Item 6. Ownership of More than Five Percent on Behalf of Another Person
"	Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
"	Item 8. Identification and Classification of Members of the Group
"	Item 9. Notice of Dissolution of Group
"	Item 10. Certification

SC 13G 1st Page of 8 TOC ↑Top Previous Next ↓Bottom Just 1st
 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549 

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934 

EuroMed, Inc. 
--------------------------------------------------------------------------------
(Name of issuer)

Common Stock, par value $0.01 per share 
--------------------------------------------------------------------------------
(Title of class of securities)

298735101 
--------------
(CUSIP Number)

*The remainder of this cover page shall be filled out for a reporting person's  
initial filing on this form with respect to the subject class of securities,    
and for any subsequent amendment containing information which would alter the   
disclosures provided in a prior cover page.                                     

The information required in the remainder of this cover page shall not be       
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange   
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of  
the Act but shall be subject to all other provisions of the Act (however, see   
the Notes).                                                                     

Page 1 of 7 Pages 

SC 13G 2nd Page of 8 TOC 1st Previous Next ↓Bottom Just 2nd
---------------------------                                ---------------------
 CUSIP No.     298735101                13G                  Page 2 of 7 Pages
---------------------------                                ---------------------

--------------------------------------------------------------------------------
1    NAME OF REPORTING PERSON                                             
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON               

Dr. A. Francois Hinnen                            

--------------------------------------------------------------------------------

   2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP *               (a) [X]
                                                                         (b) [ ]

--------------------------------------------------------------------------------

3    SEC USE ONLY                                                         

--------------------------------------------------------------------------------

4    CITIZENSHIP OR PLACE OF ORGANIZATION                                 

The Netherlands                                   
--------------------------------------------------------------------------------

   5     SOLE VOTING POWER
NUMBER OF                                                     
SHARES                           0                          
       BENEFICIALLY           --------------------------------------------------
OWNED BY             6     SHARED VOTING POWER                

EACH                                                      
REPORTING                         1,945,130                   
                              --------------------------------------------------
PERSON              7     SOLE DISPOSITIVE POWER            
WITH                                                      
       0
                              --------------------------------------------------
          8     SHARED DISPOSITIVE POWER

               1,923,130
--------------------------------------------------------------------------------
9      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON     

1,945,130                                   
--------------------------------------------------------------------------------
10     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN    
SHARES *                                                  
                                                                           [ ]

--------------------------------------------------------------------------------
11     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)                

48.91%                                      

--------------------------------------------------------------------------------
12     TYPE OF REPORTING PERSON                                         

INDIVIDUAL                                  
--------------------------------------------------------------------------------

SC 13G 3rd Page of 8 TOC 1st Previous Next ↓Bottom Just 3rd

---------------------------                                ---------------------
 CUSIP No.     298735101                13G                  Page 3 of 6 Pages
---------------------------                                ---------------------

--------------------------------------------------------------------------------
1    NAME OF REPORTING PERSON                                             
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON               

B.V. Wisteria                                     
--------------------------------------------------------------------------------

  2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP *              (a) [X]
                                                                       (b) [ ]
--------------------------------------------------------------------------------

3    SEC USE ONLY                                                         

--------------------------------------------------------------------------------

4    CITIZENSHIP OR PLACE OF ORGANIZATION                                 

The Netherlands                                   

--------------------------------------------------------------------------------
   5     SOLE VOTING POWER
NUMBER OF                                                     
SHARES                           0                          
       BENEFICIALLY           --------------------------------------------------
OWNED BY             6     SHARED VOTING POWER                

EACH                                                      
REPORTING                         1,945,130                   
                              --------------------------------------------------
PERSON              7     SOLE DISPOSITIVE POWER            
WITH                                                      
       0
                              --------------------------------------------------
          8     SHARED DISPOSITIVE POWER

               1,923,130
--------------------------------------------------------------------------------
9      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON     

1,945,130                                   

--------------------------------------------------------------------------------
10     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN    
SHARES *                                                  
                                                                             [ ]

--------------------------------------------------------------------------------
11     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)                

48.91%                                      

--------------------------------------------------------------------------------
12     TYPE OF REPORTING PERSON                                         

Limited Liability Corporation               
--------------------------------------------------------------------------------

SC 13G 4th Page of 8 TOC 1st Previous Next ↓Bottom Just 4th

---------------------------                                ---------------------
 CUSIP No.     298735101                13G                  Page 4 of 7 Pages
---------------------------                                ---------------------

--------------------------------------------------------------------------------
1    NAME OF REPORTING PERSON                                             
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON               

Pantapharma B. V.                                 
--------------------------------------------------------------------------------

  2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP *              (a) [X]
                                                                       (b) [ ]
--------------------------------------------------------------------------------

3    SEC USE ONLY                                                         

--------------------------------------------------------------------------------

4    CITIZENSHIP OR PLACE OF ORGANIZATION                                 

The Netherlands                                   

--------------------------------------------------------------------------------
   5     SOLE VOTING POWER
NUMBER OF                                                     
SHARES                           0                          
       BENEFICIALLY           --------------------------------------------------
OWNED BY             6     SHARED VOTING POWER                

EACH                                                      
REPORTING                         1,945,130                   
                              --------------------------------------------------
PERSON              7     SOLE DISPOSITIVE POWER            
WITH                                                      
       0
                              --------------------------------------------------
          8     SHARED DISPOSITIVE POWER

               1,923,130
--------------------------------------------------------------------------------
9      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON     

1,945,130                                   

--------------------------------------------------------------------------------
10     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN    
SHARES *                                                  
                                                                             [ ]

--------------------------------------------------------------------------------
11     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)                

48.91%                                      

--------------------------------------------------------------------------------
12     TYPE OF REPORTING PERSON                                         

Limited Liability Corporation               
--------------------------------------------------------------------------------

SC 13G 5th Page of 8 TOC 1st Previous Next ↓Bottom Just 5th
Item 1(a).    Name of Issuer.                                                   

EuroMed, Inc.                                       

Item 1(b).    Address of Issuer's Principal Executive Offices.                  

            Wilhelminakanaal Noord 6, NL 4092 VR Oosterhout, The Netherlands

Item 2(a).    Name of Person Filing.                                            

            Dr. A. Francois Hinnen, individually, Pantapharma B.V., a Nether
         lands private limited liability company, and B.V. Wisteria, a
Netherlands limited liability company.              

Item 2(b).    Address of Principal Business Office or, if none, Residence.      

          The principal business address of Dr. Hinnen, Pantapharma B.V.
 and B.V. Wisteria is Beekhuizenseweg 87, 6881 AG Velp

Item 2(c).    Citizenship.                                                      

             Dr. Hinnen is a citizen of The Netherlands, Pantapharma B.V. is a
            Netherlands private limited liability company, and B.V. Wisteria
is a Netherlands limited liability corporation.     

Item 2(d).    Title of Class of Securities.                                     

          Common Stock, par value of $0.01 per share ("Common Stock") of
the Issuer.                                         

Item 2(e).    CUSIP Number.                                                     

298735101                                           

Item 3.       Not Applicable.                                                   

Item 4.       Ownership.                                                        

(a)-(b)       Amount Beneficially Owned and Percent of Class.                   

                  As of December 31, 1996, 1,945,130 shares, or 48.91%, of
             the Common Stock of the Issuer were owned by B.V. Wisteria and by
            Dr. Hinnen and Pantapharma B.V. indirectly. Dr. Hinnen owns 100%
         of Pantapharma B.V. which in turn owns 100% of B.V. Wisteria.

(c)           Voting and Dispositive Power                                      

  (i)    Sole power to vote or to direct the vote of: 0.

        (ii)   shared power to vote or to direct the vote: 1,945,130

Page 5 of 7 Pages 

SC 13G 6th Page of 8 TOC 1st Previous Next ↓Bottom Just 6th
        (iii)  sole power to dispose or direct the disposition of: 0

           (iv)   Shared power to dispose or to direct the disposition of:
1,923,130                             

Item 5.              Ownership of Five Percent or Less of a Class.              

Not applicable                        

Item 6.              Ownership of More than Five Percent on Behalf of Another   
Person.                               

Not applicable                        

Item 7.              Identification and Classification of the Subsidiary Which  
               Acquired the Security Being Reported on By the Parent
Holding Company.                      

Not applicable                        

Item 8.              Identification and Classification of Members of the Group. 

Not applicable                        

Item 9.              Notice of Dissolution of Group.                            

Not applicable                        

Item 10.             Certification.                                             

Not applicable                        

Page 5 of 7 Pages 

SC 13G 7th Page of 8 TOC 1st Previous Next ↓Bottom Just 7th
---------------------------                                ---------------------
 CUSIP No.     298735101                13G                  Page 6 of 7 Pages
---------------------------                                ---------------------

    After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and  
correct.                                                                        

Date: February 13, 1997                                           

                                 By:    /s/ Dr. A. Francois Hinnen
                                           -------------------------------------
                                    Dr. A. Francois Hinnen

                           B.V. WISTERIA

                                 By:    /s/ Dr. A. Francois Hinnen
                                           -------------------------------------
                                           Dr. A. Francois Hinnen, Owner

                              PANTAPHARMA B.V.

                                 By:    /s/ Dr. A. Francois Hinnen
                                           -------------------------------------
                                           Dr. A. Francois Hinnen, Owner

SC 13G Last Page of 8 TOC 1st Previous Next ↓Bottom Just 8th
CUSIP NO. 298735101                    13G                                      

EXHIBIT A 

      Pursuant to Rule 13d-1(f)(1)(iii) of Regulation 13D of the General Rules
and Regulations of the Securities and Exchange Commission under the Securities  
Exchange Act of 1934, as amended, the undersigned agree that the statement to   
which this Exhibit is attached is filed on behalf of each of them.              

      PANTAPHARMA B.V.

                       By:    /s/ Dr. A. Francois Hinnen
                                     -----------------------------------------
                                 Dr. A. Francois Hinnen, Owner

   B.V. WISTERIA

                       By:    /s/ Dr. A. Francois Hinnen
                                      ----------------------------------------
                               Dr. A. Francois Hinnen, Owner

                          /s/ Dr. A. Francois Hinnen
                                   ---------------------------------------------
                            Dr. A. Francois Hinnen

Dated:  February 13, 1997

SC 13G	1st Page of 8	TOC	↑Top	Previous	Next	↓Bottom	Just 1st

SC 13G	2nd Page of 8	TOC	1st	Previous	Next	↓Bottom	Just 2nd

SC 13G	3rd Page of 8	TOC	1st	Previous	Next	↓Bottom	Just 3rd

SC 13G	4th Page of 8	TOC	1st	Previous	Next	↓Bottom	Just 4th

SC 13G	5th Page of 8	TOC	1st	Previous	Next	↓Bottom	Just 5th

SC 13G	6th Page of 8	TOC	1st	Previous	Next	↓Bottom	Just 6th

SC 13G	7th Page of 8	TOC	1st	Previous	Next	↓Bottom	Just 7th

SC 13G	Last Page of 8	TOC	1st	Previous	Next	↓Bottom	Just 8th

Dates Referenced Herein and Documents Incorporated by Reference

		Referenced-On Page
This ‘SC 13G’ Filing	Date	First	Last	Other Filings

Filed on:	2/14/97
	2/13/97	7	8
	12/31/96	5		10-K, 10-K/A, NT 10-K
				List all Filings

↑Top

Filing Submission 0000950134-97-001076 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Hinnen Dr A Francois, et al. – ‘SC 13G’ on 2/14/97 re: Institutional Equity Holdings Inc/NV

As of: Friday, 2/14/97 · Accession #: 950134-97-1076 · File #: 5-50045

Statement of Beneficial Ownership — Schedule 13GFiling Table of Contents

Document Table of Contents

Dates Referenced Herein and Documents Incorporated by Reference

Statement of Beneficial Ownership — Schedule 13G
Filing Table of Contents